SEC 13F Intelligence

Altium Capital Management LLC / DYN

Altium Capital Management LLC’s Dyne Therapeutics Inc Position

Does Altium Capital Management LLC own Dyne Therapeutics Inc (DYN)? Not currently — the last reported position was 315.0K shares worth $3M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q3 2023
Shares
315.0K
% of Portfolio
+1.47%
Quarters Held
7
position exited

Position History DYN

Reported value by quarter
Q1 ’21: $3MQ1 ’21Q2 ’21: $4MQ2 ’21Q3 ’21: $3MQ3 ’21Q4 ’21: $2MQ4 ’21Q1 ’23: $2MQ1 ’23Q2 ’23: $2MQ2 ’23Q3 ’23: $3MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023315.0K$3M+1.47%
Q2 2023155.0K$2M+1.32%
Q1 2023155.0K$2M+0.99%
Q4 2021166.6K$2M+0.55%
Q3 2021166.6K$3M+0.71%
Q2 2021166.6K$4M+0.81%
Q1 2021166.6K$3M+0.72%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of DYN.